CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +3,643 | 3,643 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −3,643 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +3,643 | 3,643 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −3,643 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +3,643 | 3,643 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −3,643 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +3,643 | 3,643 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −16,667 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +16,667 | 16,667 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −20,834 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +20,834 | 20,834 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Returned to the company · Stock Option (Right to Buy) | −45,000 | 0 | ||
| 2025-01-21 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2025-01-03 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +5,315,056 | 5,315,056 | ||
| 2025-01-03 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +2,207,671 | 2,207,671 | ||
| 2025-01-03 | Werner Milton H. President and CEO | Grant or award · Stock Option (Right to Buy) | +4,059,744 | 4,059,744 | ||
| 2025-01-03 | Lees-Rolfe Garth Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +470,861 | 470,861 | ||
| 2025-01-03 | Lees-Rolfe Garth Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +235,383 | 235,383 |
Page 5 of 9 · 163 trades